The Next Big Thing:...
Health Care: Drugs
Inspire Pharmaceuticals Inc. (ISPH: NASDAQ)
$5.01 0.00 | 0.00%
05/13/11 - 03:59 PM ET
989.01K / 1.77M
Vol / Avg. Vol:5.00 / 5.01
Open / Prev. Close:4.99 - 5.01
Today's Range:3.43 - 8.74
52 Wk Range:-40.36%
Performance YTD:TheStreet Rating:
Portfolios with ISPH
- Portfolio NameUser Type
- UserPART 7 JPMorgan 28th Annual...
- UserMicrocaps
- Userrubylu02
- Usersdblalock21 Portfolio 1
- Userrevenant
- Userjareen Portfolio 1
- Userwilliam feigenbaum Portfolio 1
- UserPANTERA GROUP 199
- Userjcsmith Portfolio 1
- UserBuypass Stock Picks
Latest ISPH Headlines from TheStreet
- Merck to Buy Inspire for $430 Million 04.05.11 | 10:04 am
- Inspire Pharma Plunges After Drug Trial Failure 01.03.11 | 07:01 am
- Inspire Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.04.10 | 02:11 pm
- Cramer's 'Mad Money' Recap: Next Week's Game Plan (Update 2) 10.15.10 | 06:10 pm
- Biotech Winners & Losers: Geron, Jazz Pharma 10.14.10 | 02:10 pm
- Inspire Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript 08.05.10 | 01:08 pm
- Mad Money Post Game
05.03.10 | 02:05 pm - 2 New Names to Follow 03.24.10 | 07:03 am
- Blockbuster, CalAmp: Early Volume Plays 01.21.10 | 07:01 am
- Inspire Dry Eye Drug Fails Key Test: BioBuzz 01.21.10 | 07:01 am
Press Releases for ISPH
- Inspire Reports First Quarter 2011 Financial Results - Business Wire 05.10.11 | 06:05 am
- Merck And Inspire Announce Expiration Of Hart-Scott-Rodino Act Waiting Period Relating To Tender Offer For Shares Of Inspire - Business Wire 04.28.11 | 08:04 am
- Inspire Postpones Annual Meeting Of Stockholders Due To Recently Announced Tender Offer - Business Wire 04.22.11 | 06:04 am
- Merck Commences Tender Offer For All Outstanding Shares Of Inspire Pharmaceuticals, Inc. - Business Wire 04.15.11 | 09:04 am
- The Law Offices Of Vincent Wong Announce An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Inspire Pharmaceuticals, Inc. In Connection With The Sale Of The Company To Merck – ISPH - Business Wire 04.08.11 | 10:04 am
- Faruqi & Faruqi, LLP Announces Shareholder Investigation Related To The Acquisition Of Inspire Pharmaceuticals, Inc. - ISPH - Business Wire 04.07.11 | 04:04 pm
- The Law Firm Of Weiss & Lurie Investigates The Acquisition Of Inspire Pharmaceuticals, Inc. - Business Wire 04.07.11 | 03:04 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Inspire Pharmaceuticals, Inc. - Business Wire 04.06.11 | 11:04 pm
- The Law Office Of Abe Shainberg Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Inspire Pharmaceuticals, Inc. In Connection With The Sale Of The Company To Merck – ISPH - Business Wire 04.06.11 | 06:04 pm
- Briscoe Law Firm And Powers Taylor LLP Investigate Inspire Pharmaceuticals, Inc. For Shareholders Concerning Merck Acquisition - Business Wire 04.06.11 | 11:04 am
Partner Headlines for ISPH
- Merger Arbitrage Mondays: April 11, 2011 - Seeking Alpha 04.12.11 | 06:04 am
- Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11) - Seeking Alpha 04.10.11 | 04:04 am
- Mid Afternoon Top-5 and Bottom-5 Percentage Gainers (NSM, ISPH, MRK, QCOR, PK, AAU, DGW, LEDS, MERU, WMGI, ZSTN) - Benzinga 04.05.11 | 01:04 pm
- Inspire Pharmaceuticals Resume Trading (ISPH) - Benzinga 04.05.11 | 10:04 am
- Short Ideas: 20 Small Cap Stocks With Rising Receivables - Seeking Alpha 02.04.11 | 04:02 am
- Top 16 Most Underestimated Small Cap Stocks - Seeking Alpha 01.31.11 | 09:01 am
- UPDATE 3-Inspire Pharma's cystic fibrosis drug fails; shrs sink - Reuters 01.03.11 | 12:01 pm
- Inspire Pharmaceuticals to Present Finding of Cystic Fibrosis Treatment - Fox Business 09.17.10 | 10:09 am
- UPDATE 1-Inspire Pharma posts narrower-than-expected Q1 loss - Reuters 05.03.10 | 07:05 am
- Steven Cohen's SAC Capital Raises Inspire Pharmaceuticals Stake - SeekingAlpha.com 04.27.10 | 12:04 pm
